Insider · CIK 0001545414
Jonathan P. Foster
Files at MBRX (Moleculin Biotech, Inc.), EMPD (Empery Digital Inc.). First filing Jun 23, 2025, latest Jun 23, 2025.
Jonathan P. Foster files SEC Form 4 as CFO and director at MBRX (Moleculin Biotech, Inc.), and also at EMPD (Empery Digital Inc.). Since Jun 23, 2025, Jonathan P. Foster has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Jun 23, 2025.
A track record needs three past buys with six months of prices behind them; Jonathan P. Foster has 0, so none is measured yet.
The newest scored trade: bought $100k of MBRX on Jun 23, 2025, filed Jun 23, 2025, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MBRX: Moleculin Biotech, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Moleculin Biotech, Inc. | $100k 270,270 shares | +1561% | - |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | EMPD Empery Digital Inc. | JOther Stock Option (Right to buy)derivative | -2 | $0.00 | $0 | 0 | Feb 20, 2026 |
| Feb 18, 2026 | EMPD Empery Digital Inc. | JOther Stock Option (Right to buy)derivative | -1 | $0.00 | $0 | 0 | Feb 20, 2026 |
| Feb 18, 2026 | EMPD Empery Digital Inc. | JOther Stock Option (Right to buy)derivative | -1 | $0.00 | $0 | 0 | Feb 20, 2026 |
| Nov 12, 2025 | MBRX Moleculin Biotech, Inc. | AGrant or award Stock option (right to buy)derivative | +600,000 | - | - | 1,617,695 | Nov 14, 2025 |
| Nov 12, 2025 | MBRX Moleculin Biotech, Inc. | AGrant or award Performance Based Restricted Stock Unitsderivative | +400,000 | - | - | 2,017,695 | Nov 14, 2025 |
| Nov 4, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Common Stock | +20,625 | - | - | 308,212 | Nov 6, 2025 |
| Nov 4, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Common Stock | -5,023 | $0.50 | $2,496 | 303,189 | Nov 6, 2025 |
| Nov 4, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,625 | $0.00 | $0 | 1,017,695 | Nov 6, 2025 |
| Jul 21, 2025 | EMPD Empery Digital Inc. | AGrant or award Common Stock | +20,000 | $10.00 | $200k | 20,000 | Jul 21, 2025 |
| Jul 17, 2025 | EMPD Empery Digital Inc. | AGrant or award Stock options (right to buy)derivative | +10,000 | - | - | 10,000 | Jul 21, 2025 |
| Jun 20, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Common Stock | +2,711 | - | - | 14,704 | Jun 23, 2025 |
| Jun 20, 2025 | MBRX Moleculin Biotech, Inc. | FTax withholding Common Stock | -661 | $0.27 | $176 | 14,043 | Jun 23, 2025 |
| Jun 22, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Common Stock | +4,328 | - | - | 18,371 | Jun 23, 2025 |
| Jun 22, 2025 | MBRX Moleculin Biotech, Inc. | FTax withholding Common Stock | -1,054 | $0.27 | $281 | 17,317 | Jun 23, 2025 |
| Jun 23, 2025 | MBRX Moleculin Biotech, Inc. | POpen-market purchase Common Stock | +270,270 | $0.37 | $100k | 287,587 | Jun 23, 2025 |
| Jun 20, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,711 | $0.00 | $0 | 231,838 | Jun 23, 2025 |
| Jun 22, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,328 | $0.00 | $0 | 227,510 | Jun 23, 2025 |
| Jun 23, 2025 | MBRX Moleculin Biotech, Inc. | POpen-market purchase Series E Warrantsderivative | -810,810 | - | - | 1,038,320 | Jun 23, 2025 |
| Jun 16, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Common Stock | +833 | - | - | 12,196 | Jun 18, 2025 |
| Jun 16, 2025 | MBRX Moleculin Biotech, Inc. | FTax withholding Common Stock | -203 | $0.69 | $139 | 11,993 | Jun 18, 2025 |
| Jun 16, 2025 | MBRX Moleculin Biotech, Inc. | MOption exercise Restricted Stock Unitsderivative | -833 | $0.00 | $0 | 230,684 | Jun 18, 2025 |
| Nov 4, 2024 | MBRX Moleculin Biotech, Inc. | AGrant or award Stock option (right to buy)derivative | +65,000 | - | - | 129,837 | Nov 6, 2024 |
| Nov 4, 2024 | MBRX Moleculin Biotech, Inc. | AGrant or award Restricted Stock Unitsderivative | +82,500 | - | - | 212,337 | Nov 6, 2024 |
| Oct 25, 2024 | MBRX Moleculin Biotech, Inc. | AGrant or award Performance Based Restricted Stock Unitsderivative | +19,180 | - | - | 231,517 | Nov 6, 2024 |
Questions about Jonathan P. Foster
Answered from the filings on this page, as of the latest one.
Is Jonathan P. Foster buying or selling?
Not in the last 12 months. Jonathan P. Foster's latest open-market trade on SEC Form 4 was bought $100k of MBRX on Jun 23, 2025.
How did Jonathan P. Foster's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan P. Foster has 0.
Where does Jonathan P. Foster file Form 4?
Jonathan P. Foster has filed Form 4 at MBRX (Moleculin Biotech, Inc.) as EVP & CFO; EMPD (Empery Digital Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.